Oppenheimer Asset Management Inc. Sangamo Therapeutics, Inc Transaction History

Oppenheimer Asset Management Inc.

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2020 Aug 11, 2020	SELL	$6.21 - $11.83 $161 - $307	-26 Closed	0 $0
Q1 2020 May 08, 2020	SELL	$5.05 - $8.85 $83,107 - $145,644	-16,457 Reduced 99.84%	26 $0
Q4 2019 Feb 07, 2020	BUY	$8.03 - $11.7 $4,954 - $7,218	617 Added 3.89%	16,483 $138,000
Q3 2019 Oct 31, 2019	BUY	$9.05 - $12.22 $16,570 - $22,374	1,831 Added 13.05%	15,866 $144,000
Q2 2019 Aug 09, 2019	BUY	$8.75 - $13.03 $8,776 - $13,069	1,003 Added 7.7%	14,035 $151,000
Q1 2019 Apr 24, 2019	BUY	$7.72 - $12.81 $32,300 - $53,597	4,184 Added 47.29%	13,032 $124,000
Q4 2018 Jan 30, 2019	BUY	$9.51 - $16.6 $84,144 - $146,876	8,848 New	8,848 $102,000
Q4 2017 Feb 07, 2018	SELL	$11.6 - $17.35 $72,778 - $108,853	-6,274 Closed	0 $0
Q3 2017 Nov 14, 2017	BUY	$8.4 - $15.0 $52,701 - $94,110	6,274	6,274 $94,000

110

56.8M

576K

1.17M

Ticker SGMO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 156,552,992
Market Cap $177M
Description
Sangamo Therapeutics, Inc., a clinical-stage biotechnology company, focuses on translating science into genomic medicines that transform patients' lives using platform technologies in gene therapy, cell therapy, genome editing, and genome regulation. The company offers zinc finger protein (ZFP), a technology platform for making zinc finger nucle...

Get notified when there are updates to the investment portfolio of Oppenheimer Asset Management Inc., based on Form 13F filings with the SEC.

Stay updated on Oppenheimer Asset Management Inc. with notifications on news.